- Joined
- Apr 3, 2019
- Messages
- 4,644
- Reaction score
- 10,785
Was looking at SDN year-end stuff, favorite threads, etc, and this 4 year old post from @elementaryschooleconomics… the smartest poster on SDN… struck me:
Let us harken back in our collective minds to what a sea change moment this seemed poised to be. CMS was preparing to make a blanket change to supervision levels in all hospital outpatient departments in America come Jan 1, 2020. I also would have written this was going to result in “without question negative effects for most of us.”
However I think 2019 is calling and wants its negative effects back.
I think this is an important discussion to have if only because I can remember how sky-is-falling we all were at the time. But the sky didn’t fall. What happened? Several things in my opinion…
1) ASTRO immediately discovered that image guided radiation therapy was not a therapy but a diagnostic test (and hence why ASTRO no longer calls IGRT “IGRT” anymore but instead “image guidance”).
2) Much of rad onc seemed to have ignored the potential permissiveness of blanket general supervision.
3) The change didn’t affect freestanding (yet in the meantime we have virtual supervision, yada yada).
4) A hodgepodge of varying state laws and restrictive LCDs have helped to make the Supervision Change a dog with more bark than bite?
Suffice it to say I don’t think there have been ANY negative effects from the several supervision changes in rad onc since 2019. No negative patient effects, most importantly, and no negative job market effects. This is my hypothesis… prove me wrong.
Let us learn from history.
Discuss.
I would place a footnote on this - CMS hit us totally randomly with the supervision rule change on November 1st, with uncertain but almost without question negative effects for most of us.
Blame CMS for the mid-interview season timing.
Let us harken back in our collective minds to what a sea change moment this seemed poised to be. CMS was preparing to make a blanket change to supervision levels in all hospital outpatient departments in America come Jan 1, 2020. I also would have written this was going to result in “without question negative effects for most of us.”
However I think 2019 is calling and wants its negative effects back.
I think this is an important discussion to have if only because I can remember how sky-is-falling we all were at the time. But the sky didn’t fall. What happened? Several things in my opinion…
1) ASTRO immediately discovered that image guided radiation therapy was not a therapy but a diagnostic test (and hence why ASTRO no longer calls IGRT “IGRT” anymore but instead “image guidance”).
2) Much of rad onc seemed to have ignored the potential permissiveness of blanket general supervision.
3) The change didn’t affect freestanding (yet in the meantime we have virtual supervision, yada yada).
4) A hodgepodge of varying state laws and restrictive LCDs have helped to make the Supervision Change a dog with more bark than bite?
Suffice it to say I don’t think there have been ANY negative effects from the several supervision changes in rad onc since 2019. No negative patient effects, most importantly, and no negative job market effects. This is my hypothesis… prove me wrong.
Let us learn from history.
Discuss.